CIK 0001835597 · <br>Emerging growth company
PepGen Inc.
Sign in to watch- Ticker
- PEPG
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 703-456-8000
- Business address
- 1 MARINA PARK DRIVE, SUITE 900, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-04 | Resnick Joshua Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2025-05-30 | STRECK PAUL EVP, Head of R&D | Purchase | +8,375 | $1.24 | $10K | 27,805 |
| 2025-05-20 | Kasraian Kasra Chief Technical Officer | Grant or award | +16,750 | 16,750 | ||
| 2025-05-20 | Kasraian Kasra Chief Technical Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2025-04-17 | McArthur James G President and CEO | Purchase | +10,000 | $1.36 | $14K | 113,913 |
| 2025-04-08 | McArthur James G President and CEO | Purchase | +41,500 | $1.15 | $48K | 103,913 |
| 2025-03-27 | Finer Mitchell H. Director | Grant or award · Stock Option (Right to Buy) | +26,000 | 26,000 | ||
| 2025-03-27 | Wyman Lisa Director | Grant or award · Stock Option (Right to Buy) | +26,000 | 26,000 | ||
| 2025-03-03 | DeLena Mary Beth General Counsel | Grant or award | +13,400 | 14,968 | ||
| 2025-03-03 | DeLena Mary Beth General Counsel | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2025-03-03 | Donnelly Noel Chief Financial Officer | Grant or award | +23,283 | 24,956 | ||
| 2025-03-03 | Donnelly Noel Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +104,250 | 104,250 | ||
| 2025-03-03 | STRECK PAUL EVP, Head of R&D | Grant or award | +19,430 | 19,430 | ||
| 2025-03-03 | STRECK PAUL EVP, Head of R&D | Grant or award · Stock Option (Right to Buy) | +87,000 | 87,000 | ||
| 2025-03-03 | McArthur James G President and CEO | Grant or award | +60,719 | 62,413 | ||
| 2025-03-03 | McArthur James G President and CEO | Grant or award · Stock Option (Right to Buy) | +271,875 | 271,875 | ||
| 2025-02-26 | DeLena Mary Beth General Counsel | Sale | −1,432 | $1.68 | $2K | 1,568 |
| 2025-02-26 | Donnelly Noel Chief Financial Officer | Sale | −1,527 | $1.68 | $3K | 1,673 |
| 2025-02-24 | DeLena Mary Beth General Counsel | Grant or award | +3,000 | 3,000 | ||
| 2025-02-24 | Donnelly Noel Chief Financial Officer | Grant or award | +3,200 | 3,200 |
Page 4 of 11 · 211 trades